Find Academic Supervisors

• Functional Genomics
• Population Genetics
• Natural Selection
• +4 more

Luis Barreiro is a Professor in the Department of Medicine-Genetic Medicine at the University of Chicago. His research focuses on understanding how natural selection has shaped human immune responses and how past evolutionary events influence present-day disease susceptibility through multidisciplinary approaches combining genomic, immunological, and evolutionary techniques. His educational background includes a Master's in Biotechnological Engineering from Lusófona University (2003), a PhD in Population Genetics from the University of Paris VII (2008), and postdoctoral training in Functional Genomics at the University of Chicago (2011). Dr. Barreiro's research program investigates the genetic basis of immune response variation among individuals and human populations, with particular emphasis on how natural selection has contributed to the evolution of our species. His lab combines cutting-edge genomic techniques with immunological and evolutionary genetic tools to study the phenotypic evolution of immune responses in primates, population variation in transcriptional responses to pathogens, and the mechanisms of innate immune memory. Recent work has examined how historical pandemics like the Black Death have shaped modern immune responses through natural selection. His publication record demonstrates a clear trajectory from foundational work in population genetics toward increasingly sophisticated integrations of multi-omics approaches to study gene-environment interactions in immune responses. Current research heavily focuses on trained immunity, epigenetic regulation of immune responses, and host-pathogen coevolution, with significant contributions to understanding how past selection events impact present-day disease susceptibility. Dr. Barreiro currently serves as Principal Investigator on multiple NIH-funded research projects, including R01AI190301 (2025-2030) on "Unraveling the molecular mechanisms of innate immune memory in humans," R01AI182148 (2025-2029) on "iPSC-derived macrophages as a model to study the genetic basis of inter-individual variation in immune responses to pathogens," and R35GM152227 (2024-2029) on "Characterizing the genetic and evolutionary determinants of population variation in transcriptional responses to pathogens." He leads the Barreiro Lab, which maintains strong collaborations across multiple institutions and disciplines, reflecting the integrative nature of his research program that bridges evolutionary biology, immunology, and genomics to address fundamental questions about human health and disease susceptibility.

• Foreign Languages
• Chinese Language
• Cancer Biology
• +2 more

Jianru Yang is an Adjunct Assistant Professor in the Department of Foreign Language at Virginia Commonwealth University, specializing in Chinese language instruction. This role involves teaching within the College of Humanities and Sciences framework, though the specific school affiliation is not detailed in the source text. Professor Yang's academic profile reflects dual expertise: (1) Foreign language education with a focus on Chinese linguistics and pedagogy, and (2) Cutting-edge biomedical research in cancer biology and immunology. Their interdisciplinary research explores: Molecular mechanisms of cancer progression (e.g., MDA-9/Syntenin signaling, tumor microenvironment) Immunotherapeutic strategies (vaccine development, immune checkpoint modulation) Metabolic reprogramming in disease (fatty acid oxidation, sphingolipid pathways) Inflammation regulation (NLRP3 inflammasome, scavenger receptors) Analysis of 15 recent publications (2022-2024) reveals consistent focus on translational oncology, with themes spanning cancer immunotherapy development, metastasis biology, immune cell dysfunction, and therapeutic target validation across multiple cancer types (lung, prostate, melanoma, breast). Research methodologies frequently integrate molecular biology, preclinical models, and immunometabolism.

• Genetics
• Plant Biology
• Root Development
• +3 more

Jose Manuel Pérez Pérez is a Professor in the Department of Applied Biology at the Miguel Hernández University of Elche , where he directs the Genetics of Plant Regeneration and Reproductive Development research group. His work focuses on plant genetics and developmental biology, particularly the molecular mechanisms underlying root system architecture and adventitious root formation. Primary Research Areas: Genetics, Plant Molecular Biotechnology, Root Development, Epigenetics, Stress Response Recent Trends: Hormonal signaling (auxin, ABA, ethylene), transcriptional networks in plant regeneration, epigenetic regulation of root formation, stress-induced architectural adaptations The Institute of Bioengineering hosts his laboratory, where he investigates molecular responses to abiotic stress, chromatin dynamics in root meristems, and hormone-metabolic interactions. Key methodologies include transcriptomics, molecular docking, and in vitro propagation systems.

• Cancer Nanomedicine
• Molecular Imaging
• Nano-Immunotherapy
• +3 more

Dr. Alexandros Marios Sofias is head of the "Immune Cell Targeting and Imaging" Research Group at the Institute for Experimental Molecular Imaging (ExMI) of RWTH Aachen University, Germany, and Co-Chair of the Image-Guided Drug Delivery (IGDD) Study Group of the European Society for Molecular Imaging (ESMI). Education: PhD in Nanomedicine (2019) MSc in Pharmaceutical Sciences (2016) Diploma in Pharmacy (2014) Research Focus: His laboratory integrates in vivo multimodal imaging with advanced nanomedicine design to decode the fate of therapeutic nanoparticles and to develop nano-immunotherapeutics that reprogram the tumor immune microenvironment. Core themes include: Real-time tracking of nanoparticle biodistribution via intravital microscopy and PET/MRI. Leveraging immune cells (neutrophils, macrophages) as active carriers (“hitchhiking”) to enhance tumor targeting. Engineering 3-D vascularized tumor models for preclinical validation. Translational development of core-crosslinked polymeric micelles and lipid nanoparticles for image-guided drug delivery. Publication Trends: Across >25 high-impact papers since 2020, Sofias has consistently advanced the intersection of nanomedicine, molecular imaging, and cancer immunotherapy. His work has progressively shifted from passive EPR-based targeting to active immune-cell-mediated delivery, emphasizing real-time imaging feedback to optimize therapy. Grants & Collaborations: Although specific grant numbers are not listed, the extensive co-authorship network with Kiessling, Lammers, Storm, Mulder and others indicates substantial national (DFG, BMBF) and European (ERC, Horizon Europe) funding streams. The team participates in large consortia such as the ESMI IGDD study group. Labs & Teams: He leads the “Immune Cell Targeting and Imaging” group housed within the state-of-the-art ExMI building at RWTH Aachen, equipped with preclinical PET/MRI, high-resolution intravital microscopy, nanoformulation suites, and 3-D bioprinting facilities.

• Cancer Metastasis
• Metabolic Reprogramming
• Epigenetics
• +3 more

Oliver Gene McDonald, M.D., Ph.D., is an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Miami Miller School of Medicine. He directs the Gastrointestinal Pathology Research Program and the Pathology Physician-Scientist Program, focusing on translational pathology research support for cancer investigators. Education: 2007: MD, PhD in Medicine, University of Virginia School of Medicine 2000: BS in Biology, University of Tennessee-Martin 2011: Anatomic Pathology Residency, The Johns Hopkins Hospital 2013: Gastrointestinal Pathology Fellowship, The Johns Hopkins Hospital Research Interests: His work explores how adaptive metabolism reprograms the pancreatic cancer epigenome, enabling metastasis through self-maintained chromatin states. Clinical research emphasizes histomorphology and molecular pathogenesis of gastrointestinal and pancreaticobiliary diseases. The lab investigates reversible epigenetic programs and their therapeutic targeting. Scientific Awards: STAR Award for High Impact Cancer Research, Vanderbilt-Ingram Cancer Center John Yardley Fellowship in Gastrointestinal Pathology Outstanding Graduate Student Award, University of Virginia Jill E. Hungerford Outstanding Molecular Medicine Graduate Student Award, University of Virginia Outstanding Trainee Achievement Award, University of Virginia Professional Activities: He lectures at institutions like Sanford Burnham Prebys Medical Discovery Institute and the University of South Alabama, and serves on committees for the Sylvester Comprehensive Cancer Center and Medical Scientist Training Program.

Marcin TabakaView profile

Researcher

• Computational Genomics
• Single-Cell Genomics
• Cell Reprogramming
• +3 more

Marcin Tabaka, PhD is a Group Leader at the International Centre for Translational Eye Research (ICTER), which is part of the Institute of Physical Chemistry, Polish Academy of Sciences in Warsaw, Poland. He leads the Computational Genomics Group focused on applying high-throughput single-cell genomics technologies to diverse research areas including eye research, cell reprogramming, immunology, and cancer. Dr. Tabaka graduated from the Jagiellonian University Faculty of Chemistry in 2004 and obtained his PhD at the Institute of Physical Chemistry, Polish Academy of Science (IPC PAS) in 2009. He completed postdoctoral training in Mathematical Biology at IPC PAS (2010-2014) followed by research at the Klarman Cell Observatory headed by Aviv Regev at the Broad Institute of MIT and Harvard (2014-2019). He established his independent research group at ICTER in September 2020. His research focuses on computational approaches to single-cell genomics, with applications in translational eye research and disease mechanisms. His work spans multiple disciplines including: Computational biology and bioinformatics Single-cell and single-nucleus RNA sequencing Developmental biology and cell reprogramming Immunology and cancer biology Retinal degeneration and eye disease mechanisms Dr. Tabaka's research group has developed several computational tools for single-cell data analysis, including the recently published "Ocelli" open-source platform for developmental multimodal single-cell data analysis. His work demonstrates strong interdisciplinary collaboration between computational biology, molecular biology, and clinical research, particularly in the field of ophthalmology. Dr. Tabaka is actively involved in mentoring researchers and collaborating on multiple interdisciplinary projects, though specific students are not listed in the available information. His research is supported by institutional funding from ICTER and likely external grants related to his publications in high-impact journals. He leads the Computational Genomics Group at ICTER, which maintains strong collaborations with international research institutions including the Broad Institute of MIT and Harvard. The group combines computational expertise with experimental approaches to address fundamental questions in genomics and translational medicine, particularly in the context of eye diseases.

Thomas J. VelenosiView profile

Assistant Professor

• Pharmacometabolomics
• Pharmacology
• Metabolomics
• +7 more

Thomas J. Velenosi is an Assistant Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia. He received his PhD in pharmacology and toxicology from Western University and completed his postdoctoral fellowship at the National Cancer Institute (National Institutes of Health). His research focuses on the intersection of pharmacology and metabolomics, particularly in cancer therapy and biomarker discovery. Institution: University of British Columbia Faculty: Faculty of Pharmaceutical Sciences Academic Rank: Assistant Professor Dr. Velenosi's research interests center around pharmacometabolomics, metabolomics, lipidomics, mass spectrometry, cancer biology, stable isotope tracing, and bioinformatics. His lab applies advanced analytical techniques to study drug treatment response and toxicity during cancer therapy, with a particular focus on identifying and characterizing metabolic biomarkers. His approach combines highly translational cancer models with computational methods to improve biomarker identification and clinical validation. The Velenosi lab's research focuses on two main areas: 1) developing computational methods for improving mass spectrometry-based metabolomics, lipidomics and stable isotope tracing, and 2) applying these techniques to cutting-edge cancer models to identify and characterize metabolic biomarkers and therapeutic targets. His work aims to bridge the gap between biomarker identification and clinical validation to facilitate personalized therapy for cancer patients. His research has resulted in numerous publications in high-impact journals, with a focus on cancer metabolism, kidney function biomarkers, and metabolic reprogramming. The most recent publications (2022-2025) show a strong trend toward precision medicine applications, particularly in triple-negative breast cancer, with emphasis on polyamine metabolism and biomarker discovery for treatment response prediction. Postdoctoral Fellowship, Canadian Institutes of Health Research, 2018 Canada Graduate Scholarship - Doctoral (CGS-D) Award, Natural Sciences and Engineering Research Council of Canada, 2012 Dr. Velenosi actively supervises graduate students in the Pharmaceutical Sciences and Bioinformatics programs, training them in state-of-the-art mass spectrometry, molecular biology, tissue culture, and animal cancer models. His lab utilizes highly controlled patient-derived xenograft models to identify and characterize metabolic biomarkers of drug effectiveness. The Velenosi lab is currently accepting applications for MSc and PhD students interested in studying metabolic biomarkers of drug response in cancer. The lab maintains a collaborative environment with regular social events, as evidenced by their summer pizza outings and holiday parties, fostering a strong team dynamic focused on advancing precision medicine for cancer treatment through metabolomics research.

• Colorectal Cancer
• Wnt Signalling
• Tumor Suppressor Genes
• +3 more

Professor Owen J Sansom serves as the Director of the Institute of Cancer Sciences at the CRUK Scotland Institute, affiliated with the University of Glasgow. His research primarily focuses on colorectal cancer, particularly the role of the Apc gene and Wnt signalling in intestinal tumorigenesis. He employs inducible mouse models to study early neoplastic changes, aiming to identify novel therapeutic targets and biomarkers. Key research interests include: colorectal cancer mechanisms, Wnt pathway dysregulation, tumor suppressor functions, pancreatic and liver malignancies, cancer metabolism, and the tumor microenvironment. His work integrates molecular biology, genetics, and preclinical modeling to address therapy resistance and metastasis. Professor Sansom leads several research groups at the Beatson Institute, specializing in Pancreatic, Colorectal/Lower GI/Intestinal/Gut Microbiome, and Liver cancers. His team collaborates extensively on projects involving cancer heterogeneity, immune modulation, and precision oncology.

• Biomaterials
• Tissue Engineering
• Cancer Mechanobiology
• +5 more

Dr. Chantal Kopecky is a Lecturer at the University of New South Wales (UNSW) Sydney, affiliated with the School of Chemistry and working in the Kilian Lab within the field of Biomaterials and Tissue Engineering. She earned her PhD in Immunology from the Medical University of Vienna, Austria in 2015, specializing in cardiovascular and lipoprotein biology in chronic kidney disease, followed by an MSc in Nutrition Science from the University of Vienna in 2009. Her research spans multiple disciplines at the intersection of biomaterials, cancer biology, and metabolic disease. Dr. Kopecky's work focuses on cancer mechanobiology, developing 3D tumor microenvironments, and investigating metabolic complications in diabetes and cardiovascular disease. She has extensively utilized advanced techniques like 3D lightsheet fluorescence microscopy to visualize pathologic processes and immune cell involvement in diseases such as atherosclerosis. Her current research in the Kilian Lab centers on biomaterials approaches to cancer therapy, particularly in pancreatic cancer where she previously worked in the Pancreatic Cancer Translational Research Group from 2018-2020. Analysis of her recent publications reveals a strong focus on nanomedicine applications for cancer treatment, particularly using ceria-based nanoparticles for EGFR-targeted therapies. Her work bridges materials science with biological applications, creating innovative hydrogel platforms to model tumor microenvironments and test novel therapeutics. She has also maintained significant research in cardiovascular disease, particularly examining the renin-angiotensin system in diabetic kidney disease. UNSW Sydney School of Medical Sciences Paper of the Month award (2019) Travel grant of the Australian Atherosclerosis Society (2018) Abstract Prize of the Austrian Diabetes Society (2017) Young Investigator Fellowship of the European Society of Atherosclerosis (2016) Clinical Science award of the Austrian Society of Transplantation, Transfusion and Genetics (2015) Hans-Krister-Stummvoll prize of the Austrian Society of Nephrology (2014) Dr. Kopecky has secured multiple research grants including as Primary Investigator for the 2020-2021 project on innovative nanomedicines for pancreatic cancer drug delivery, as Secondary Investigator for the 2019-2021 MyoRobot biomechatronics project, and as Applicant and Secondary Investigator for the 2016-2020 study on empagliflozin's effects on the renin-angiotensin system. Her laboratory work in the Kilian Lab focuses on evaluating nanomedicine therapeutics in vitro and in vivo to demonstrate metabolic reprogramming in pancreatic cancer, utilizing state-of-the-art 3D lightsheet fluorescence microscopy to characterize tumor morphology and immune cell profiles.

Megan MadonnaView profile

Assistant Professor

• Cancer Research
• Biomedical Engineering
• Optical Imaging
• +3 more

Megan Madonna is an Assistant Research Professor in the Department of Biomedical Engineering at Duke University, where she earned her Ph.D. in 2020. She teaches multiple Bass Connections research teams (ISS 796T/795T/396T/395T) focused on Information, Society & Culture, alongside engineering project courses including BME 493/494, BME 462L, BME 791, and EGR 393. Her research centers on optical metabolic imaging to investigate cancer metabolism, particularly in breast cancer subtypes. She develops advanced multi-probe and multi-scale imaging platforms capable of simultaneously quantifying metabolic and vascular endpoints such as fatty acid uptake, mitochondrial activity, and oxygen saturation in vivo. Her work specifically targets chemoresistance mechanisms in triple-negative and Her2+ breast cancer, identifying metabolic vulnerabilities during residual disease and recurrence. Analysis of her 15 most recent publications reveals a consistent focus on translating optical imaging techniques into clinical applications for cancer therapy guidance. Her work demonstrates strong interdisciplinary collaboration, particularly with Dr. Nimmi Ramanujam's lab, and spans from fundamental metabolic imaging development to clinical implications for chemotherapy monitoring. Dr. Madonna actively mentors students through graduate independent study (BME 791) and capstone projects (BME 493/494), while leading interdisciplinary Bass Connections teams that integrate engineering with societal considerations. She contributes to Duke's Global Women's Health Technologies ecosystem through her editorial work on gender-specific biomedical research.

Adnane SellamView profile

Associate Professor

• Fungal Pathogenesis
• Genomics and Systems Biology
• Antifungal Drug Discovery
• +3 more

Dr. Adnane Sellam is an Associate Professor in the Department of Microbiology-Infectiology and Immunology at the University of Montreal and a researcher at the Montreal Heart Institute. He previously held positions at Laval University and CHU de Québec. His research integrates genomics and systems biology to study fungal pathogenesis in opportunistic yeasts like Candida albicans and C. auris . Research Focus: His program investigates: 1) Hypoxia's impact on fungal virulence and fitness, 2) Discovery of novel antifungal molecules (including clinical-phase candidates against fungal vaginosis), and 3) Coordination of growth and cell division mechanisms in pathogenic yeasts. His work bridges fundamental biology with therapeutic development. Funding & Collaboration: Supported by federal (CIHR, NSERC, CFI) and provincial (FRQS, CQDM) agencies, Merck-Frost, and international collaborators. Current lab members include PhD student Inès Khemiri and research associate Faiza Tebbji.

Gabriel MujicaView profile

Assistant Professor

• Networked Embedded Systems
• Internet of Things
• Wireless Sensor Networks
• +3 more

Gabriel Mujica is an Assistant Professor at the Technical University of Madrid (UPM), where he is affiliated with the Centre of Industrial Electronics. His research focuses on Networked Embedded Systems and the Internet of Things (IoT), with particular expertise in Wireless Sensor Networks (WSN) and urban mesh networking for smart city applications. His educational background includes: BE in Electrical and Electronics Engineering, Federal University of Paraíba (UFC/FRP), 2008 MSc in Industrial Electronics Engineering, Technical University of Madrid, 2012 PhD in Industrial Electronics Engineering, Technical University of Madrid, 2017 Dr. Mujica's research interests center on multi-hop distributed networks, hardware-software co-design for intelligent platforms, and communication protocols for embedded sensing systems. He has extensive experience in the development and optimization of Wireless Sensor Networks, integration of heterogeneous hardware and software, and performance evaluation of sensor platforms. His current work targets urban mesh networking for smart applications, with a focus on sustainable cities and leveraging collaborations from his doctoral research at Trinity College Dublin. His publications reveal a strong emphasis on practical implementations of Wireless Sensor Networks and IoT. Key themes include deployment strategies, performance evaluation, and tool development for WSN commissioning and maintenance. His work often bridges hardware and software, addressing challenges in energy efficiency, dynamic reprogramming, and multi-experimental capabilities in distributed embedded systems. No scientific awards were mentioned in the provided text. Dr. Mujica has co-supervised undergraduate projects and internships for international students, and has contributed to several national and European research projects. He has also organized research tutorials and seminars at UPM and served as a reviewer for international conferences and journals including IEEE and Springer. His doctoral research stay at Trinity College Dublin strengthened collaborations in distributed systems for smart and sustainable cities. He is an active member of the Centre of Industrial Electronics at UPM, where his team has developed integrated toolsets for WSN application planning, development, and maintenance, notably within the ARTEMIS-JU project. His lab focuses on implementing embedded platforms for urban mesh networking and smart application scenarios.

Sui Seng TeeView profile

Assistant Professor

• Metabolism
• Hyperpolarized Magnetic Resonance Spectroscopy
• Cancer Research
• +5 more

Sui Seng Tee is an Assistant Professor at the Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine. His research focuses on the intersection of signaling pathways and cellular metabolism using hyperpolarized magnetic resonance spectroscopy for metabolic imaging and therapeutic applications. Education PhD Biochemistry, University of Cambridge, UK (2011) BA (Hons) Natural Science, University of Cambridge, UK (2007) Postdoctoral Research Fellow, Stanford University, CA (2014) Research Associate, Memorial Sloan Kettering Cancer Center, NY (2018) Research Interests Dr. Tee's work centers on metabolic imaging and signaling networks in disease states, particularly cancer and metabolic disorders. His lab develops hyperpolarized MRI techniques to visualize real-time metabolic flux and investigates fructose metabolism in hepatocellular carcinoma. Publication trends show strong focus on metabolic reprogramming (2014-2025), hyperpolarized imaging (2014-2016), and signal transduction in cancer metabolism (2017-2019). Scientific Contributions NIH R21CA245492-01A1 (Principal Investigator) NIH R21AG084142 (mPI) Pioneered hyperpolarized MRI reporter gene technology

John PowersView profile

Assistant Professor

• RNA Biology
• Neuroblastoma
• Cancer Genetics
• +3 more

John Powers is an Assistant Professor in the Department of Pediatrics and Courtesy Assistant Professor in the Department of Oncology at Dell Medical School, University of Texas at Austin, where he leads RNA biology research targeting pediatric neuroblastoma as a CPRIT Scholar. His academic credentials include: Bachelor's degree in Microbiology from University of Texas at Austin Ph.D. in Molecular Genetics and Microbiology from University of Texas at Austin Postdoctoral training at Harvard Medical School and Boston Children's Hospital focusing on microRNA biology and cancer genetics Dr. Powers' research centers on deciphering MYCN-driven mechanisms in neuroblastoma through RNA biology, with dual therapeutic approaches: developing RNA-based treatments and creating low-cost personalized cancer vaccines. Core research pillars encompass: MYCN amplification and dysregulation pathways RNA therapeutics for high-risk neuroblastoma Personalized vaccine platforms for targeted cancer therapy His publication record reveals consistent focus on neuroblastoma pathogenesis since 2010, with recent work (2024-2025) emphasizing lipid metabolism interactions with MYCN, noncoding RNA mechanisms, and translational applications of RNA biology. The research trajectory demonstrates evolution from fundamental molecular mechanisms to preclinical therapeutic development. Professional recognition includes: CPRIT Scholar award from Cancer Prevention and Research Institute of Texas Dr. Powers directs the Powers Lab at Dell Pediatric Research Institute, where his team investigates RNA-based interventions for pediatric cancers. His industry background at Moderna Therapeutics informs the lab's translational approach to therapeutic development, particularly in cellular genetic engineering for cancer vaccines.

Valeria ChionoView profile

Professor

• Cardiac Tissue Engineering
• 3D Bioprinting
• Nanomedicine
• +7 more

Valeria Chiono serves as a Full Professor in the Department of Mechanical and Aerospace Engineering (DIMEAS) at Polytechnic University of Turin. She holds multiple leadership positions including Deputy Coordinator of the Doctoral College in Bioengineering and Medical-Surgical Sciences, Member of the Interdepartmental Center PolitoBIOMed Lab - Biomedical Engineering Lab, and Member of the Research Ethics Committee (ARI). Her academic career spans significant contributions to biomedical engineering with expertise in cardiac tissue engineering, nanomedicine, and advanced drug delivery systems. Dr. Chiono's research focuses on biomimetic materials for cardiac regeneration, including hydrogels for drug delivery, 3D bioprinting of cardiac tissues, and non-viral gene therapy using polymer-lipid nanoparticles. Her work emphasizes green technologies that utilize polymers from food industry byproducts and agricultural waste, minimizing organic solvent use. Key research areas include cardiac tissue engineering , in vitro tissue models (blood-brain barrier, fibrotic cardiac tissue, skin models), and antimicrobial coatings . Her recent publications demonstrate a strong trend toward precision nanomedicine for cardiac regeneration , with significant focus on microRNA delivery systems, engineered cardiac tissue models, and biomimetic scaffolds. The research consistently bridges fundamental biomaterials science with clinical applications in cardiovascular medicine, featuring collaborations across European institutions and industry partners. Award highlights include: Back Cover in Advanced Healthcare Materials (2020) BioPmed Award 2014 - Gold As a dedicated mentor, Dr. Chiono supervises numerous PhD students in the Bioengineering and Medical-Surgical Sciences program, with current students working on cardiac regeneration, nanomedicine, and tissue engineering projects. She has secured substantial research funding including multiple European Research Council (ERC) grants such as BIORECAR and DESIRE, and coordinates national projects under Italy's PNRR initiative. Her laboratory work centers on the BIOINSIDE LAB within DIMEAS, developing innovative platforms for cardiac tissue modeling and drug delivery. The research integrates advanced manufacturing techniques, biomaterials science, and cellular reprogramming strategies to address unmet needs in cardiac regeneration.